MultiCell Technologies Inc (MCET)

[murocman]

This is a different issue. As I look through the MultiCell website, their focus on adult stemcells from the liver. Adult stemcells are already in use and have shown excellent promise in multiple therapies.

Embryonic cells get more press but adult stem cells have more near-term potential.

Bottomline, I don't think the story you reference is the reason for this move. The volume is too high and the move too great. There is something else going on that the public isn't privy to yet, but obviously somebody thinks it's good news.

Murocman